Dr Reddy's buys Novartis cardiovascular brand Cidmus in India for Rs 456 crore - Economic Times

Dr. Reddys will look to leverage its wide base to engage with healthcare professionals, and to significantly enhance the reach of the product in and beyond metros into tier-I and tier-II markets in India through its strong marketing and distribution network t…

Dr. Reddy's on Friday said it has entered into an agreement with Novartis to acquire the cardiovascular brand Cidmus in India for Rs 456 crore ($61 million). Under the agreement, Dr. Reddys will be … [+1587 chars]

full article...